FOLH1 and pachyonychia congenita: It can be employed as a PSMA-specific ligand.85 Although this system may be an excellent tool for PC diagnosis and targeted drug delivery to PC, to date, no study on the use of this system for miRNA delivery via PSMA targeting in PC has been reported.